Burkholderia Pseudomallei Infections Drug Market
Global Burkholderia Pseudomallei Infections Drug Market Size, Share & Trends Analysis Report By Type (Cholinesterase Inhibitors And Memantine), And By Application (Hospital, Clinic And Other) Forecast 2022-2028
The global burkholderia pseudomallei infections drug market is anticipated to grow at a considerable CAGR. Burkholderia pseudomallei is a bacteria that was considered an endemic at the end of the twentieth century. It is mostly found in soil and surface water. B pseudomallei enters the human body through any cut or wounds on the body. It can be asymptomatic at the start and can only show mild fever and cough. Patients who have a high level of CRP and PCT are more suspected to get a bacterial infection. PCT helps in distinguishing between bacterial and nonbacterial disease and is a better diagnostic marker. The normal PCT level in the body is 0.00-0.05 ng/ML and if someone has a PCT level of 1.03 ng/ML then the body is likely to get infected by a bacterial disease. Blood cultures must be performed in these cases as acute blood infections are caught if these conditions are not taken care of. It is a rare disease. For instance, in Sept 2021, according to the center for disease control and prevention, in the US four cases of melioidosis were identified. These cases were in four different states of the US which marked two deaths.
Impact of COVID-19 Pandemic on Global Burkholderia pseudomallei infections drug market
Covid-19 pandemic has affected every sector of the world in some way. Burkholderia pseudomallei infections drug market saw a decline due to nationwide lockdown in almost all the countries of the world. Hospital facilities and medical centers were closed and were open to only emergency services. Treatment of bacterial infections needs blood diagnosis and further follow up which was not possible during this time.
Segmental Outlook
The global burkholderia pseudomallei infections drug market is segmented based on type and application. Based on type, the market is segmented into cholinesterase inhibitors and memantine. Based on application the market is sub-segmented into hospital, clinic, and other.
Global Burkholderia Pseudomallei Infections Drug Market Share by Type, 2021 (%)
Cholinesterase Inhibitors are Anticipated to Hold a Prominent Share in the Global Burkholderia pseudomallei infections drug market
Cholinesterase Inhibitors are anticipated to hold a prominent market share in the global burkholderia pseudomallei infections drug market during the forecast period. These drugs are also called acetylcholinesterase inhibitors. The main function of acetylcholine is that it acts as a neurotransmitter found in the body and performs functions in the central nervous system. Cholinesterase Inhibitors help in blocking the action of Cholineste. This breaks down the acetylcholine. These drugs are mainly used for treating nerve disorders such as dementia. For instance, in June 2021, Aduhelm injection was approved by FDA which will be used for treating Alzheimer’s disease. This will provide more treatment options for the disease.
Regional Outlooks
The global burkholderia pseudomallei infections drug market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The Asia Pacific is anticipated to lead the burkholderia pseudomallei infections drug market during the forecast period.
Global Burkholderia Pseudomallei Infections Drug Market Growth, by Region 2022-2028
Asia-Pacific is Estimated to Hold the Major Share in the Global Burkholderia Pseudomallei Infections Drug Market
Geographically, it is anticipated that the major share of the market will be taken by Asia-Pacific, and this region will lead during the forecast period. Cases of melioidosis which is caused by burkholderia pseudomallei bacteria have been found in this region. This bacteria can be seen in places like unchlorinated water and plants in tropical regions. Burkholderia pseudomallei bacteria can survive in any condition even if it is not given nutrients. For instance, in Feb 2022, according to an article published in cureus, b pseudomallei bacteria is mostly found in southeast Asia. It is also found in nonendemic regions such as Saudi Arabia. Traces of this bacteria was found in a Bangladeshi man who was working in Saudi Arabia.
Market Players Outlook
The major companies serving the global burkholderia pseudomallei infections drug market include Janssen Pharmaceuticals, Novartis AG, Biogen, Algi Pharma AS, Bavarian Nordic A/S, and others. The market players are adopting different market strategies such as mergers and acquisitions, new product launches, business expansion, partnership collaboration, and others. For instance, in Dec 2021, Professor Siobhan McClean of the University College of Dublin has invented a vaccine for melioidosis which is caused by b pseudomallei bacteria. Poolbeg pharma which works in the area of developing a treatment for infections has signed a declaration to license the vaccine. The vaccine is named as MelioVac.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Burkholderia pseudomallei infections drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Burkholderia Pseudomallei Infections Drug Market
• Recovery Scenario of Global Burkholderia Pseudomallei Infections Drug Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Janssen Pharmaceuticals
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Novartis AG
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Biogen Inc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Algi Pharma AS
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Bavarian Nordic A/S
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Burkholderia Pseudomallei Infections Drug Market by Type
4.1.1. Cholinesterase inhibitors
4.1.2. Memantine
4.2. Global Burkholderia Pseudomallei Infections Drug Market by END-USER
4.2.1. Hospital
4.2.2. Clinic
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Emergent biosolutions Inc.
6.2. Forge Therapeutics Inc.
6.3. Grifols SA
6.4. MerLion Pharmaceuticals GmBh
6.5. Soligenix, Inc.
6.6. Syntiron LLC
6.7. Venatorx Pharmaceuticals, Inc.
1. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL CHOLINESTERASE INHIBITORS IN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL MEMANTINE IN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
5. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN OTHER END-USER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
11. NORTH AMERICAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
12. EUROPEAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. EUROPEAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. EUROPEAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS TYPE, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
18. REST OF THE WORLD BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. REST OF THE WORLD BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. REST OF THE WORLD BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET, 2021-2027 (%)
4. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL CHOLINESTERASE INHIBITORS IN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL MEMANTINE IN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SHARE BY END-USER, 2021 VS 2028 (%)
8. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN HOSPITAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG IN OTHER END-USER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. US BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
13. CANADA BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
14. UK BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
15. FRANCE BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
16. GERMANY BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
17. ITALY BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
19. REST OF EUROPE BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
20. INDIA BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
21. CHINA BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
22. JAPAN BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF ASIA-PACIFIC BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD BURKHOLDERIA PSEUDOMALLEI INFECTIONS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
